Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akihiro Hirakawa

Showing results (1-10 of 374) with videos related to

Pageof 38
Sort By:
Statistics in Medicine|November 24, 2011
An adaptive dose-finding approach for correlated bivariate binary and continuous outcomes in phase I oncology trialsAkihiro Hirakawa
Statistics in Medicine|May 7, 2014
Response to letter to the editor by Dr Wages et alAkihiro Hirakawa, Shigeyuki Matsui
Surgery|March 27, 2014
Reply to: appropriate statistical descriptions for evaluating the predictive role of epithelial-to-mesenchymal transition in patients with pancreatic cancerSuguru Yamada, Akihiro Hirakawa
Statistics in Medicine|January 14, 2016
Authors' ReplyAkihiro Hirakawa, Hiroyuki Sato
Therapeutic Innovation & Regulatory Science|September 21, 2018
An Analysis of Japanese Patients Enrolled in Multiregional Clinical Trials in OncologyAkihiro Hirakawa, Fumie Kinoshita
Pharmaceutical Statistics|August 12, 2020
A Bayesian basket trial design accounting for uncertainties of homogeneity and heterogeneity of treatment effect among subpopulationsJunichi Asano, Akihiro Hirakawa
Journal of Biopharmaceutical Statistics|March 22, 2017
Assessing the prediction accuracy of a cure model for censored survival data with long-term survivors: Application to breast cancer dataJunichi Asano, Akihiro Hirakawa
Statistics in Medicine|February 18, 2017
Comparison of conditional bias-adjusted estimators for interim analysis in clinical trials with survival dataMasashi Shimura, Masahiko Gosho, Akihiro Hirakawa
Statistics in Medicine|May 8, 2013
A dose-finding approach based on shrunken predictive probability for combinations of two agents in phase I trialsAkihiro Hirakawa, Chikuma Hamada, Shigeyuki Matsui
Journal of Biopharmaceutical Statistics|November 6, 2014
A Dose-Finding Method Based on Multiple Dosing in Two-Agent Combination Phase I TrialsYasuyuki Kakurai, Akihiro Hirakawa, Chikuma Hamada
Pageof 38

Showing results (1-10 of 374) with videos related to

Sort By:
Pageof 38
Statistics in Medicine|November 24, 2011
An adaptive dose-finding approach for correlated bivariate binary and continuous outcomes in phase I oncology trialsAkihiro Hirakawa
Statistics in Medicine|May 7, 2014
Response to letter to the editor by Dr Wages et alAkihiro Hirakawa, Shigeyuki Matsui
Surgery|March 27, 2014
Reply to: appropriate statistical descriptions for evaluating the predictive role of epithelial-to-mesenchymal transition in patients with pancreatic cancerSuguru Yamada, Akihiro Hirakawa
Statistics in Medicine|January 14, 2016
Authors' ReplyAkihiro Hirakawa, Hiroyuki Sato
Therapeutic Innovation & Regulatory Science|September 21, 2018
An Analysis of Japanese Patients Enrolled in Multiregional Clinical Trials in OncologyAkihiro Hirakawa, Fumie Kinoshita
Pharmaceutical Statistics|August 12, 2020
A Bayesian basket trial design accounting for uncertainties of homogeneity and heterogeneity of treatment effect among subpopulationsJunichi Asano, Akihiro Hirakawa
Journal of Biopharmaceutical Statistics|March 22, 2017
Assessing the prediction accuracy of a cure model for censored survival data with long-term survivors: Application to breast cancer dataJunichi Asano, Akihiro Hirakawa
Statistics in Medicine|February 18, 2017
Comparison of conditional bias-adjusted estimators for interim analysis in clinical trials with survival dataMasashi Shimura, Masahiko Gosho, Akihiro Hirakawa
Statistics in Medicine|May 8, 2013
A dose-finding approach based on shrunken predictive probability for combinations of two agents in phase I trialsAkihiro Hirakawa, Chikuma Hamada, Shigeyuki Matsui
Journal of Biopharmaceutical Statistics|November 6, 2014
A Dose-Finding Method Based on Multiple Dosing in Two-Agent Combination Phase I TrialsYasuyuki Kakurai, Akihiro Hirakawa, Chikuma Hamada
Pageof 38